乳化ががんの特徴に及ぼす影響 (レビュー)
Yujie Fan1, Zhangda Chen1, Jiaxin Li1
1Department of General Surgery, Wenzhou Medical University Lishui Hospital and Lishui City People's Hospital, Lishui, Zhejiang 323000, P.R. China.
Oncology letters
|September 3, 2025
まとめ
乳糖化,代謝変化,がんとの関連性
科学分野:
- 生物化学
- 癌 生物学
- エピジェネティクス
背景:
- ラクチレーションは,新興の翻訳後の修正である.
- 癌の代謝再プログラムと表遺伝子調節を 結びつけています
研究 の 目的:
- 乳化が癌の特徴を 駆動する方法を検討する.
- 腫瘍の微小環境 (TME) の役割を探求する.
- ラクチレーションを標的とした治療戦略を強調する.
主な方法:
- 既存の文献の体系的なレビュー
- ヒストンおよび非ヒストンタンパク質における乳酸の調節作用の分析.
- 乳化が癌の特徴とTMEに与える影響の検討
主要な成果:
- ラクティレーションは,古典的および新興がんの特徴を調節する.
- 免疫抑制性TMEを形成し,治療抵抗性を促進する.
- 乳化が代謝の再プログラム,免疫脱出,表遺伝的変化に影響する.
結論:
- 乳糖化が癌の進行と治療抵抗の主要な要因である.
- 乳化経路をターゲットにすることで 新しい精密な抗がん戦略が生まれます
- 乳化調節による代謝-表遺伝的交響を遮断することは 有望な治療法です
関連する概念動画
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...


